Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-y...
Singapore: Singapore based biotechnology firm, Austrianova, has received Board of Investment (BOI) status for its Thai s...
Singapore: Singapore's gross expenditure on R&D (GERD) recorded a new high of S$7.4 billion in 2011, according to t...
Singapore: Scientists at A*STAR's Genome Institute of Singapore (GIS) have successfully developed a method to map the ep...
Singapore: Scientists from Singapore have identified FAIM, a molecule that typically prevents cell death, as a potential...
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Korean Health Industry Development Insti...
The rising demand for cost containment in healthcare and the need to improve quality of services are driving the growth ...
Singapore: Telecommunication companies in Asia-Pacific are increasingly exploring vertical markets like healthcare to op...
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...
Singapore: A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancer...
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...
Singapore: Boehringer Ingelheim has reported that in Asian populations, Pradaxa (dabigatran etexilate) offers considerab...
Singapore: Covance expanded its central laboratory facility in Singapore to enhance the company's current service offeri...
Singapore: A*STAR's Institute of Microelectronics (IME) and SFC Fluidics, a USA microfluidics-based biomedical device d...
Singapore: Biomedical association of Singapore, BioSingapore has appointed Mr Simranjit Singh, director, strategic plann...
Singapore: A team of National University of Singapore (NUS) researchers from Departments of Bioengineering and Orthopaed...
Singapore: National University of Singapore (NUS) has taken a new research initiative called the NUS Synthetic Biology f...
Singapore: Critical Diagnostics, a US-based biomarker company focused on cardiovascular diseases, added two distribution...
